The therapeutic promise of stem cells is immense and is by no means a pipe dream. An excellent example of this is the transplant of hematopoietic stem cells for the treatment of hematopoietic malignancies, which is now routine clinical practice.
A major challenge in furthering the therapeutic potential of stem cells (both adult and embryonic) lies in appropriate manipulation of these cells in culture. Over the past few years, much progress have been made in stem cell culture methods – in the latest free webinar (Oct 10, 2013), Dr. Kevin Eggan (HHMI, Harvard Stem Cell Institute) cover the latest, state-of-the-art methods in working with stem cells.
Related: Stem cell engineering special issue of Biotechnology Journal, edited by Prof. Brenda Ogle and Prof. Sean Palecek
The Asian Congress on Biotechnology (ACB) is organized every two years by the Asian Federation of Biotechnology. The second ACB 2013 will be held in New Delhi, December 15-19, 2013.